Articles

Prolonged use of hormonal contraceptives slightly increases the risk for breast cancer. Read More ›

Intraventricular HER2 CAR T-cell therapy may be an option for patients with HER2+ breast cancer and brain metastasis. Read More ›

In the phase 3 OlympiAD trial, treatment with olaparib significantly improved progression-free survival and reduced the risk for disease progression or death compared with standard chemotherapy in women with HER2-negative, BRCA-mutated metastatic breast cancer. Read More ›

PD-L1 positivity in all cells in patients with breast cancer may be a useful prognostic marker based on a recent meta-analysis. Read More ›

A new analysis shows that there is an ongoing, steady risk for metastatic or distant recurrence of cancer from years 5 to 20 among women with estrogen receptor–positive breast cancer. Read More ›

After accounting for the benefit of pertuzumab, investigators found that >6 cycles of docetaxel did not significantly improve progression-free or overall survival in patients with HER2-positive, metastatic breast cancer. Read More ›

Abemaciclib offers a new option for women with HR-positive, HER2-negative advanced metastatic breast cancer. Read More ›

Dr Bruner has had a distinguished career, marked by many awards (most recently, induction into the National Academy of Medicine), the publication of more than 150 peer-reviewed journal articles, and the distinction of being the first and only nurse to lead a National Cancer Institute cooperative group—the Radiation Therapy Oncology Group’s Community Clinical Oncology Program. Read More ›

Immune checkpoint inhibitor therapy is a relatively recent advance in the treatment of several types of cancer and has received much media attention. As healthcare professionals gain more experience with checkpoint inhibitors, it is important for them to understand that the toxicity profiles of these drugs differ from those of chemotherapeutic agents. Read More ›

The National Comprehensive Cancer Network estimates that at least 33% of patients with cancer have significant psychological distress, and many patients have some levels of distress. Read More ›